These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16370154)

  • 21. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autonomic dysregulation in patients awaiting kidney transplantation.
    Hathaway DK; Cashion AK; Milstead EJ; Winsett RP; Cowan PA; Wicks MN; Gaber AO
    Am J Kidney Dis; 1998 Aug; 32(2):221-9. PubMed ID: 9708605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men.
    Lampert R; Bremner JD; Su S; Miller A; Lee F; Cheema F; Goldberg J; Vaccarino V
    Am Heart J; 2008 Oct; 156(4):759.e1-7. PubMed ID: 18926158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cross-sectional study of relation between blood pressure and heart rate variability in patients with peritoneal dialysis].
    Li LX; Tang W; Chen BJ; Wang T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):849-54. PubMed ID: 22178833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients.
    Tsirpanlis G; Boufidou F; Manganas S; Chantzis K; Bleta A; Stamatelou K; Psimenou E; Nicolaou C
    Blood Purif; 2004; 22(6):518-24. PubMed ID: 15557765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study.
    Stein PK; Barzilay JI; Chaves PH; Traber J; Domitrovich PP; Heckbert SR; Gottdiener JS
    J Am Geriatr Soc; 2008 Feb; 56(2):315-21. PubMed ID: 18179502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study.
    Chang YM; Shiao CC; Huang YT; Chen IL; Yang CL; Leu SC; Su HL; Kao JL; Tsai SC; Jhen RN; Uen CC;
    Cardiovasc Diabetol; 2016 Jan; 15():16. PubMed ID: 26817599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.
    Hamaad A; Sosin M; Blann AD; Patel J; Lip GY; MacFadyen RJ
    Clin Cardiol; 2005 Dec; 28(12):570-6. PubMed ID: 16405201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart rate variability, left ventricular functions, and cardiac autonomic neuropathy in patients undergoing chronic hemodialysis.
    Karayaylali I; San M; Kudaiberdieva G; Niyazova-Karben Z; Seyrek N; Balal M; Paydas S; Sagliker Y
    Ren Fail; 2003 Sep; 25(5):845-53. PubMed ID: 14575292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory markers and heart rate variability in women with coronary heart disease.
    Janszky I; Ericson M; Lekander M; Blom M; Buhlin K; Georgiades A; Ahnve S
    J Intern Med; 2004 Nov; 256(5):421-8. PubMed ID: 15485478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure.
    Babaei M; Dashti N; Lamei N; Abdi K; Nazari F; Abbasian S; Gerayeshnejad S
    Acta Med Iran; 2014; 52(12):893-8. PubMed ID: 25530051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients.
    Chang YM; Shiao CC; Chang KC; Chen IL; Yang CL; Leu SC; Su HL; Kao JL; Tsai SC; Jhen RN
    Clin Exp Nephrol; 2016 Aug; 20(4):650-659. PubMed ID: 26511876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients.
    Heidari B; Fazli MR; Misaeid MA; Heidari P; Hakimi N; Zeraati AA
    Clin Exp Nephrol; 2015 Aug; 19(4):725-31. PubMed ID: 25380841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?
    Yigit IP; Celiker H; Dogukan A; Ilhan N; Gurel A; Ulu R; Aygen B
    Ren Fail; 2015 Feb; 37(1):77-82. PubMed ID: 25347233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage renal disease patients: one year prospective study.
    Dursun B; Demircioglu F; Varan HI; Basarici I; Kabukcu M; Ersoy F; Ersel F; Suleymanlar G
    Ren Fail; 2004 Jan; 26(1):35-8. PubMed ID: 15083919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum fetuin-A levels, QT dispersion and P dispersion in dialysis patients.
    Taskapan MC; Taskapan H; Comert M; Temel I; Yagmur J; Ulutas O
    Ren Fail; 2013; 35(4):477-82. PubMed ID: 23438291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of heme oxygenase-1 and inflammatory factors in patients with end-stage renal failure following hemodialysis].
    Wu F; Yu L; Zhang ZM; Shi HB
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):368-70. PubMed ID: 17425995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of chronic inflammation on bone turnover in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Antoniadi G; Kazila P; Dimitriadou M; Sotiriadou E; Koltsida M; Golfinopoulos S; Liakopoulos V; Christopoulou-Apostolaki M
    Ren Fail; 2008; 30(4):431-7. PubMed ID: 18569918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.